Abstract
The management of ulcerative colitis-associated dysplasia (UCAD) has evolved over the last decade. Many have advocated for increased utilization of endoscopic resection of dysplastic lesions, mainly driven by improved endoscopic techniques [1, 2]. This has occurred in spite of significant inter-rater variability with respect to the pathological diagnoses, shifting taxonomy, evidence that low-grade dysplasia may not progress to high-grade dysplasia prior to malignancy, and with heterogeneous reported rates of synchronous and metachronous neoplasia [1–8].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489–501 e26.
Mark-Christensen A, Laurberg S, Haboubi N. Dysplasia in inflammatory bowel disease: historical review, critical histopathological analysis, and clinical implications. Inflamm Bowel Dis. 2018; https://doi.org/10.1093/ibd/izy075.
Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657–68.
Connelly TM, Koltun WA. The surgical treatment of inflammatory bowel disease-associated dysplasia. Expert Rev Gastroenterol Hepatol. 2013;7:307–21.. quiz 22
Althumairi AA, Lazarev MG, Gearhart SL. Inflammatory bowel disease associated neoplasia: a surgeon’s perspective. World J Gastroenterol. 2016;22:961–73.
Murphy J, Kalkbrenner KA, Blas JV, et al. What is the likelihood of colorectal cancer when surgery for ulcerative-colitis-associated dysplasia is deferred? Color Dis. 2016;18:703–9.
Fumery M, Dulai PS, Gupta S, et al. Incidence, risk factors, and outcomes of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15:665–74 e5.
Huang LC, Merchea A. Dysplasia and cancer in inflammatory bowel disease. Surg Clin North Am. 2017;97:627–39.
Ross H, Steele SR, Varma M, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. 2014;57:5–22.
Oresland T, Bemelman WA, Sampietro GM, et al. European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis. 2015;9:4–25.
Cleveland NK, Ollech JE, Colman RJ, et al. Efficacy and follow-up of subtotal colectomy with ileorectal anastomoses in patients with colitis-associated neoplasia. Clin Gastroenterol Hepatol. 2019;17(1):205–6.
Abdalla M, Landerholm K, Andersson P, Andersson RE, Myrelid P. Risk of rectal cancer after colectomy for patients with ulcerative colitis: a national cohort study. Clin Gastroenterol Hepatol. 2017;15:1055–60 e2.
Lindberg J, Stenling R, Palmqvist R, Rutegard J. Surgery for neoplastic changes in ulcerative colitis--can limited resection be justified? Outcome for patients who underwent limited surgery. Color Dis. 2006;8:551–6.
Uzzan M, Kirchgesner J, Oubaya N, et al. Risk of rectal neoplasia after colectomy and ileorectal anastomosis for ulcerative colitis. J Crohns Colitis. 2017;11:930–5.
Derikx L, Nissen LHC, Smits LJT, Shen B, Hoentjen F. Risk of neoplasia after colectomy in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:798–806.. e20
Al-Sukhni W, McLeod RS, MacRae H, O’Connor B, Huang H, Cohen Z. Oncologic outcome in patients with ulcerative colitis associated with dyplasia or cancer who underwent stapled or handsewn ileal pouch-anal anastomosis. Dis Colon Rectum. 2010;53:1495–500.
Tonelli F, Di Martino C, Giudici F. Could total colectomy with ileorectal anastomosis be an alternative to total proctocolectomy with ileal pouch-anal anastomosis in selected ulcerative colitis patients? Gastroenterol Res Pract. 2016;2016:5832743.
Andersson P, Norblad R, Soderholm JD, Myrelid P. Ileorectal anastomosis in comparison with ileal pouch anal anastomosis in reconstructive surgery for ulcerative colitis—a single institution experience. J Crohns Colitis. 2014;8:582–9.
da Luz Moreira A, Kiran RP, Lavery I. Clinical outcomes of ileorectal anastomosis for ulcerative colitis. Br J Surg. 2010;97:65–9.
Murphy J, Kalkbrenner KA, Pemberton JH, et al. Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer. Dis Colon Rectum. 2014;57:993–8.
Siegel CA, Schwartz LM, Woloshin S, et al. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis. 2010;16:1658–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Brar, M.S., de Buck van Overstraeten, A. (2019). Surgical Options for Endoscopically Unresectable Dysplasia in Ulcerative Colitis. In: Hyman, N., Fleshner, P., Strong, S. (eds) Mastery of IBD Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-16755-4_29
Download citation
DOI: https://doi.org/10.1007/978-3-030-16755-4_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16754-7
Online ISBN: 978-3-030-16755-4
eBook Packages: MedicineMedicine (R0)